|
|
As a global leader in high-performance bioanalytical measurement systems, Molecular Devices empowers researchers to advance scientific discovery and drug development with innovative imaging and screening solutions.
97% Accurate Label-Free Detection with AI
Preserve cell viability and streamline workflows using deep learning-based segmentation.
Download NowTraditional imaging is costly and compromises cell health. Our latest study shows how IN Carta® Software uses AI to achieve high-accuracy results without fluorescent labels.
- Preserve Viability: Non-invasive, real-time monitoring.
- Proven Accuracy: 97% correlation with DAPI staining.
- Broad Application: Validated across U2OS, HeLa, and HCT116.
Download the application note to see how AI transforms label-free analysis for phenotypic screening.